Another study revealed that, plasma Cystatin-C can moderately predict AKI (AUC-ROC 0.68) and all-cause death or HF hospitalization (AUC-ROC, 95% confidence interval: 0.73, 0.66–0.80), in acute HF patients [42,43]. This evidence concerns the gene CST3 and acute kidney injury.